Impact of hormone replacement therapy on all‐cause and cancer‐specific mortality in colorectal cancer: A systematic review and dose‒response meta‐analysis of observational studies
Authors:
- 20 June 2024
- journal article
- research article
- Published by Wiley in Journal of Evidence-Based Medicine
- Vol. 17 (2) , 377-389
Abstract
Objective: The effect of hormone replacement therapy (HRT) on colorectal cancer (CRC) mortality and all‐cause mortality remains unclear. We conducted a systematic review and dose–response meta‐analysis to determine the effects of HRT on CRC mortality and all‐cause mortality.Methods: We searched the electronic databases of PubMed, Embase, and The Cochrane Library for all relevant studies published until January 2024 to investigate the effects of HRT exposure on survival rates for patients with CRC. Two reviewers independently extracted individual study data and evaluated the risk of bias between the studies using the Newcastle‒Ottawa Scale. We performed a two‐stage random‐effects dose–response meta‐analysis to examine a possible nonlinear relationship between the year of HRT use and CRC mortality.Results: Ten cohort studies with 480,628 individuals were included. HRT was inversely associated with the risk of CRC mortality (hazard ratios (HR) = 0.77, 95% CI (0.68, 0.87), I2 = 69.5%, p < 0.05). The pooled results of seven cohort studies revealed a significant association between HRT and the risk of all‐cause mortality (HR = 0.71, 95% CI (0.54, 0.92), I2 = 89.6%, p < 0.05). A linear dose–response analysis (p for nonlinearity = 0.34) showed a 3% decrease in the risk of CRC for each additional year of HRT use; this decrease was significant (HR = 0.97, 95% CI (0.94, 0.99), p < 0.05). An additional linear (p for nonlinearity = 0.88) dose–response analysis showed a nonsignificant decrease in the risk of all‐cause mortality for each additional year of HRT use.Conclusions: This study suggests that the use of HRT is inversely associated with all‐cause and colorectal cancer mortality, thus causing a significant decrease in mortality rates over time. More studies are warranted to confirm this association.Keywords
All Related Versions
Funding Information
- Natural Science Foundation of Sichuan Province (2022NSFSC1314)
This publication has 44 references indexed in Scilit:
- Use of hormone replacement therapy improves the prognosis in patients with colorectal cancer: A population‐based study in SwedenInternational Journal of Cancer, 2017
- Review: Cochrane handbook for systematic reviews for interventions, Version 5.1.0, published 3/2011. Julian P.T. Higgins and Sally Green, EditorsResearch Synthesis Methods, 2011
- The effect of estrogen vs. combined estrogen‐progestogen therapy on the risk of colorectal cancerInternational Journal of Cancer, 2011
- Extending DerSimonian and Laird's methodology to perform multivariate random effects meta‐analysesStatistics in Medicine, 2010
- Dose‐response analyses using restricted cubic spline functions in public health researchStatistics in Medicine, 2010
- Oral contraceptive use, hormone replacement therapy, reproductive history and risk of colorectal cancer in womenInternational Journal of Cancer, 2007
- Hormone Replacement Therapy, Reproductive History, and Colorectal Adenomas: Data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial (United States)Cancer Causes & Control, 2005
- Meta-analysis of Observational Studies in EpidemiologyA Proposal for ReportingJAMA, 2000
- Estrogen replacement therapy and colorectal cancer risk in elderly womenDiseases of the Colon & Rectum, 1999
- Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy—long-term follow-up of a Swedish cohortInternational Journal of Cancer, 1996